Total Clarity Wealth Management, Inc. Edwards Lifesciences Corp Transaction History

Total Clarity Wealth Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$86.5 - $128.27 $116,169 - $172,266	1,343 New	1,343 $128,000
Q1 2022 Apr 29, 2022	SELL	$101.96 - $128.34 $52,203 - $65,710	-512 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$106.37 - $130.68 $9,998 - $12,283	-94 Reduced 15.51%	512 $66,000
Q3 2021 Oct 21, 2021	BUY	$102.91 - $122.75 $62,363 - $74,386	606 New	606 $69,000
Q2 2021 Jul 26, 2021	SELL	$83.84 - $104.76 $21,463 - $26,818	-256 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$78.68 - $90.67 $20,142 - $23,211	256 New	256 $21,000
Q1 2020 Apr 24, 2020	SELL	$52.41 - $81.0 $2,987 - $4,617	-57 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$71.7 - $82.09 $4,086 - $4,679	57 New	57 $13,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.